<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_pathogenesis" title="Does the Microbiota Play a Pivotal Role in the Pathogenesis of Irritable Bowel Syndrome?" shortTitle="pathogenesis" author="Sharmila Fagoonee, Rinaldo Pellicano" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2077-0383/8/11/1808/htm" speakerList="none" speakerCount="0">
<p>
<s type="decl">
The	DT	the
microbial	JJ	microbial
community	NN	community
that	WDT	that
lives	VBZ	life
in	IN	in
the	DT	the
human	JJ	human
body	NN	body
,	,	,
called	VBN	call
the	DT	the
microbiota	NN	microbiota
,	,	,
consists	VBZ	consist
of	IN	of
a	DT	a
large	JJ	large
variety	NN	variety
of	IN	of
microorganisms	NNS	microorganism
including	VBG	include
bacteria	NNS	bacteria
,	,	,
viruses	NNS	virus
,	,	,
fungi	NNS	fungi
,	,	,
eukaryotes	NNS	eukaryote
and	CC	and
archae	NN	archae
.	.	.
</s>
<s type="decl">
Every	DT	every
human	JJ	human
being	NN	being
harbors	VBZ	harbor
between	IN	between
10	CD	10
trillion	CD	1000000000000
and	CC	and
100	CD	100
trillion	CD	1000000000000
microbial	JJ	microbial
cells	NNS	cell
,	,	,
which	WDT	which
is	VBZ	be
approximately	RB	approximately
equal	JJ	equal
to	IN	to
10	CD	10
times	NNS	time
the	DT	the
total	JJ	total
number	NN	number
of	IN	of
body	NN	body
cells	NNS	cell
.	.	.
</s>
<s type="decl">
The	DT	the
term	NN	term
microbiome	NN	microbiome
refers	VBZ	refer
to	IN	to
the	DT	the
gene	NN	gene
set	NN	set
of	IN	of
these	DT	this
microbial	JJ	microbial
cells	NNS	cell
.	.	.
</s>
<s type="decl">
The	DT	the
gut	NN	gut
microbiome	NN	microbiome
is	VBZ	be
estimated	VBN	estimate
to	TO	to
contain	VB	contain
over	RB	over
150	CD	150
times	NNS	time
more	JJR	more
genes	NNS	gene
than	IN	than
the	DT	the
human	JJ	human
genome	NN	genome
.	.	.
</s>
<s type="decl">
During	IN	during
long-standing	JJ	long-standing
interactions	NNS	interaction
,	,	,
a	DT	a
mutual	JJ	mutual
co-evolution	NN	co-evolution
between	IN	between
gut	NN	gut
microbiota	NNS	microbiota
and	CC	and
the	DT	the
host	NN	host
occurs	VBZ	occur
,	,	,
with	IN	with
the	DT	the
former	JJ	former
making	VBG	make
an	DT	a
important	JJ	important
contribution	NN	contribution
to	IN	to
human	JJ	human
metabolism	NN	metabolism
,	,	,
with	IN	with
significant	JJ	significant
effects	NNS	effect
on	IN	on
the	DT	the
anatomical	JJ	anatomical
,	,	,
physiological	JJ	physiological
,	,	,
and	CC	and
immunological	JJ	immunological
development	NN	development
of	IN	of
the	DT	the
host	NN	host
.	.	.
</s>
<s type="decl">
Considering	VBG	consider
that	IN	that
many	JJ	many
bacterial	JJ	bacterial
species	NNS	species
still	RB	still
cannot	MD	cannot
be	VB	be
cultured	VBN	culture
,	,	,
our	PRP$	our
understanding	NN	understanding
of	IN	of
gut	NN	gut
microbiota	NN	microbiota
has	VBZ	have
evolved	VBN	evolve
over	IN	over
the	DT	the
past	JJ	past
few	JJ	few
years	NNS	year
thanks	NNS	thanks
to	IN	to
the	DT	the
availability	NN	availability
of	IN	of
advanced	JJ	advanced
molecular	JJ	molecular
methods	NNS	method
that	WDT	that
permit	VBP	permit
us	PRP	we
to	TO	to
identify	VB	identify
a	DT	a
large	JJ	large
quantity	NN	quantity
of	IN	of
microorganisms	NNS	microorganism
.	.	.
</s>
<s type="decl">
Today	NN	today
,	,	,
it	PRP	it
is	VBZ	be
known	VBN	know
that	IN	that
although	IN	although
98	CD	98
%	NN	%
of	IN	of
the	DT	the
gut	NN	gut
microbiota	NN	microbiota
is	VBZ	be
composed	VBN	compose
of	IN	of
four	CD	4
phyla	NNS	phyla
of	IN	of
bacteria	NNS	bacteria
(	-LRB-	(
Firmicutes	NNPS	Firmicutes
,	,	,
Bacteroidetes	NNPS	Bacteroidetes
,	,	,
Proteobacteria	NNP	Proteobacteria
and	CC	and
Actinobacteria	NNP	Actinobacteria
)	-RRB-	)
,	,	,
the	DT	the
majority	NN	majority
are	VBP	be
either	CC	either
Firmicutes	NNPS	Firmicutes
or	CC	or
Bacteroidetes	NNPS	Bacteroidetes
.	.	.
</s>
<s type="decl">
With	IN	with
this	DT	this
premise	NN	premise
,	,	,
in	IN	in
the	DT	the
last	JJ	last
decade	NN	decade
,	,	,
the	DT	the
gut	NN	gut
microbiota	NN	microbiota
has	VBZ	have
become	VBN	become
a	DT	a
key	JJ	key
topic	NN	topic
in	IN	in
the	DT	the
investigation	NN	investigation
of	IN	of
several	JJ	several
gastrointestinal	JJ	gastrointestinal
(	-LRB-	(
GI	NNP	GI
)	-RRB-	)
as	RB	as
well	RB	well
as	IN	as
extra-GI	JJ	extra-GI
diseases	NNS	disease
.	.	.
</s>
</p>
<p>
<s type="decl">
Irritable	JJ	Irritable
bowel	NN	bowel
syndrome	NN	syndrome
(	-LRB-	(
IBS	NNP	IBS
)	-RRB-	)
is	VBZ	be
a	DT	a
common	JJ	common
functional	JJ	functional
clinical	JJ	clinical
condition	NN	condition
characterized	VBN	characterize
by	IN	by
abdominal	JJ	abdominal
discomfort	NN	discomfort
or	CC	or
pain	NN	pain
and	CC	and
alteration	NN	alteration
of	IN	of
gut	NN	gut
habits	NNS	habit
without	IN	without
an	DT	a
underlying	JJ	underlie
structural	JJ	structural
pathology	NN	pathology
.	.	.
</s>
<s type="decl">
As	IN	as
IBS	NNP	IBS
affects	VBZ	affect
9	CD	9
–	SYM	-
23	CD	23
%	NN	%
of	IN	of
the	DT	the
general	JJ	general
population	NN	population
,	,	,
with	IN	with
considerable	JJ	considerable
impact	NN	impact
on	IN	on
quality	NN	quality
of	IN	of
life	NN	life
and	CC	and
health	NN	health
care	NN	care
resource	NN	resource
utilization	NN	utilization
,	,	,
it	PRP	it
represents	VBZ	represent
an	DT	a
important	JJ	important
medical	JJ	medical
challenge	NN	challenge
in	IN	in
term	NN	term
of	IN	of
diagnosis	NN	diagnosis
and	CC	and
treatment	NN	treatment
.	.	.
</s>
<s type="decl">
The	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
IBS	NNP	IBS
remains	VBZ	remain
unclear	JJ	unclear
,	,	,
with	IN	with
several	JJ	several
factors	NNS	factor
supposed	VBN	suppose
to	TO	to
be	VB	be
involved	VBN	involve
,	,	,
including	VBG	include
environmental	JJ	environmental
and	CC	and
host	NN	host
factors	NNS	factor
such	JJ	such
as	IN	as
psychosocial	JJ	psychosocial
stressors	NNS	stressor
,	,	,
food	NN	food
intolerance	NN	intolerance
,	,	,
antibiotics	NNS	antibiotics
,	,	,
enteric	JJ	enteric
infections	NNS	infection
,	,	,
altered	VBN	alter
pain	NN	pain
perception	NN	perception
,	,	,
altered	VBN	alter
brain	NN	brain
–	:	-
gut	NN	gut
interactions	NNS	interaction
,	,	,
dysbiosis	NN	dysbiosis
(	-LRB-	(
imbalance	NN	imbalance
within	IN	within
the	DT	the
bacterial	JJ	bacterial
community	NN	community
)	-RRB-	)
,	,	,
increased	VBN	increase
intestinal	JJ	intestinal
permeability	NN	permeability
,	,	,
increased	VBN	increase
gut	NN	gut
mucosal	JJ	mucosal
immune	JJ	immune
activation	NN	activation
and	CC	and
visceral	JJ	visceral
hypersensitivity	NN	hypersensitivity
.	.	.
</s>
</p>
<p>
<s type="decl">
In	IN	in
recent	JJ	recent
years	NNS	year
,	,	,
the	DT	the
relationship	NN	relationship
between	IN	between
gut	NN	gut
microbiota	NN	microbiota
and	CC	and
brain	NN	brain
–	:	-
gut	NN	gut
interactions	NNS	interaction
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
IBS	NNP	IBS
has	VBZ	have
become	VBN	become
a	DT	a
key	JJ	key
topic	NN	topic
in	IN	in
clinical	JJ	clinical
and	CC	and
biomedical	JJ	biomedical
research	NN	research
.	.	.
</s>
<s type="decl">
This	DT	this
issue	NN	issue
has	VBZ	have
been	VBN	be
accurately	RB	accurately
discussed	VBN	discuss
in	IN	in
a	DT	a
recent	JJ	recent
review	NN	review
by	IN	by
Quigley	NNP	Quigley
.	.	.
</s>
<s type="decl">
Beginning	VBG	begin
with	IN	with
an	DT	a
excursus	NN	excursus
on	IN	on
the	DT	the
historical	JJ	historical
steps	NNS	step
that	WDT	that
led	VBD	lead
to	IN	to
the	DT	the
definition	NN	definition
of	IN	of
the	DT	the
gut	NN	gut
–	SYM	-
brain	NN	brain
axis	NN	axis
,	,	,
the	DT	the
author	NN	author
discussed	VBD	discuss
the	DT	the
modern	JJ	modern
theory	NN	theory
that	WDT	that
postulates	VBZ	postulate
the	DT	the
involvement	NN	involvement
of	IN	of
gut	NN	gut
microbiota	NN	microbiota
in	IN	in
both	CC	both
the	DT	the
gut	NN	gut
–	:	-
brain	NN	brain
axis	NN	axis
and	CC	and
IBS	NNP	IBS
.	.	.
</s>
<s type="sub">
On	IN	on
the	DT	the
basis	NN	basis
of	IN	of
this	DT	this
theory	NN	theory
,	,	,
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
IBS	NNP	IBS
would	MD	would
be	VB	be
related	VBN	relate
to	IN	to
the	DT	the
action	NN	action
of	IN	of
central	JJ	central
stimuli	NNS	stimulus
,	,	,
such	JJ	such
as	IN	as
stress	NN	stress
,	,	,
that	WDT	that
could	MD	could
disrupt	VB	disrupt
mucosal	JJ	mucosal
immunity	NN	immunity
,	,	,
reduce	VB	reduce
microbial	JJ	microbial
diversity	NN	diversity
and	CC	and
alter	VB	alter
gut	NN	gut
barrier	NN	barrier
function	NN	function
,	,	,
leading	VBG	lead
to	IN	to
gut	NN	gut
dysfunction	NN	dysfunction
.	.	.
</s>
<s type="decl">
Although	IN	although
much	JJ	much
work	NN	work
still	RB	still
needs	VBZ	need
to	TO	to
be	VB	be
done	VBN	do
,	,	,
there	EX	there
is	VBZ	be
evidence	NN	evidence
to	TO	to
support	VB	support
this	DT	this
pathogenetic	JJ	pathogenetic
model	NN	model
.	.	.
</s>
</p>
<p>
<s type="decl">
First	RB	first
,	,	,
it	PRP	it
has	VBZ	have
been	VBN	be
shown	VBN	show
that	IN	that
fecal	JJ	fecal
and	CC	and
colonic	NN	colonic
microbiota	NN	microbiota
compositions	NNS	composition
in	IN	in
patients	NNS	patient
with	IN	with
IBS	NNP	IBS
are	VBP	be
different	JJ	different
compared	VBN	compare
to	IN	to
healthy	JJ	healthy
subjects	NNS	subject
.	.	.
</s>
<s type="decl">
For	IN	for
example	NN	example
,	,	,
the	DT	the
count	NN	count
of	IN	of
gene	NN	gene
copies	NNS	copy
or	CC	or
the	DT	the
number	NN	number
of	IN	of
colony	NN	colony
forming	VBG	form
units	NNS	unit
of	IN	of
<hi rend="italic">
Lactobacilli	NNP	Lactobacilli
</hi>
and	CC	and
<hi rend="italic">
Bifidobacteria	NNP	Bifidobacteria
</hi>
are	VBP	be
compromised	VBN	compromise
while	IN	while
those	DT	this
of	IN	of
<hi rend="italic">
Escherichia	NNP	Escherichia
coli	NN	coli
</hi>
and	CC	and
<hi rend="italic">
Enterobacter	NNP	Enterobacter
</hi>
are	VBP	be
increased	VBN	increase
in	IN	in
IBS	NNP	IBS
patients	NNS	patient
.	.	.
</s>
<s type="sub">
Furthermore	RB	furthermore
,	,	,
a	DT	a
specific	JJ	specific
gut	NN	gut
microbiota	NN	microbiota
signature	NN	signature
(	-LRB-	(
low	JJ	low
microbial	JJ	microbial
diversity	NN	diversity
,	,	,
absence	NN	absence
of	IN	of
<hi rend="italic">
Methanobacteriales	NNPS	Methanobacteriales
</hi>
and	CC	and
enrichment	NN	enrichment
with	IN	with
<hi rend="italic">
Bacteroides	NNP	Bacteroides
</hi>
)	-RRB-	)
could	MD	could
be	VB	be
linked	VBN	link
to	IN	to
the	DT	the
severity	NN	severity
of	IN	of
IBS	NNP	IBS
.	.	.
</s>
</p>
<p>
<s type="decl">
Second	RB	second
,	,	,
the	DT	the
benefits	NNS	benefit
reported	VBN	report
in	IN	in
some	DT	some
studies	NNS	study
after	IN	after
antibiotic	JJ	antibiotic
or	CC	or
probiotic	JJ	probiotic
administration	NN	administration
on	IN	on
IBS	NNP	IBS
symptoms	NNS	symptom
are	VBP	be
proof	NN	proof
in	IN	in
favor	NN	favor
of	IN	of
a	DT	a
role	NN	role
of	IN	of
microbiota	NN	microbiota
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
this	DT	this
disease	NN	disease
.	.	.
</s>
<s type="decl">
Data	NNS	data
from	IN	from
animal	NN	animal
models	NNS	model
provides	VBZ	provide
a	DT	a
plausible	JJ	plausible
explanation	NN	explanation
for	IN	for
this	DT	this
benefit	NN	benefit
.	.	.
</s>
<s type="decl">
It	PRP	it
has	VBZ	have
been	VBN	be
shown	VBN	show
that	IN	that
probiotics	NNS	probiotics
can	MD	can
enhance	VB	enhance
the	DT	the
intestinal	JJ	intestinal
mucosal	JJ	mucosal
barrier	NN	barrier
and	CC	and
increase	VB	increase
the	DT	the
number	NN	number
of	IN	of
butyrate-producing	VBG	butyrate-produce
bacteria	NNS	bacteria
.	.	.
</s>
<s type="decl">
The	DT	the
augmented	VBN	augment
production	NN	production
of	IN	of
short-chain	JJ	short-chain
fatty	NN	fatty
acids	NNS	acid
(	-LRB-	(
SCFAs	NNS	SCFAs
)	-RRB-	)
,	,	,
such	JJ	such
as	IN	as
butyric	NN	butyric
and	CC	and
acetic	NN	acetic
acid	NN	acid
,	,	,
acidizes	VBZ	acidize
the	DT	the
gut	NN	gut
and	CC	and
facilitates	VBZ	facilitate
the	DT	the
beneficial	JJ	beneficial
colonization	NN	colonization
of	IN	of
<hi rend="italic">
Lactobacillus	NNP	Lactobacillus
</hi>
and	CC	and
<hi rend="italic">
Bifidobacterium	NNP	Bifidobacterium
</hi>
species	NNS	species
.	.	.
</s>
<s type="decl">
Whatever	WDT	whatever
the	DT	the
precise	JJ	precise
mechanism	NN	mechanism
,	,	,
the	DT	the
poorly	RB	poorly
absorbed	VBN	absorb
antibiotic	JJ	antibiotic
rifaximin	NN	rifaximin
and	CC	and
probiotics	NNS	probiotics
or	CC	or
prebiotics	NNS	prebiotics
provided	VBD	provide
relief	NN	relief
against	IN	against
the	DT	the
cardinal	JJ	cardinal
IBS	NNP	IBS
symptoms	NNS	symptom
.	.	.
</s>
<s type="decl">
For	IN	for
these	DT	this
reasons	NNS	reason
,	,	,
recent	JJ	recent
international	JJ	international
guidelines	NNS	guideline
suggest	VBP	suggest
to	TO	to
prescribe	VB	prescribe
probiotics	NNS	probiotics
in	IN	in
this	DT	this
context	NN	context
.	.	.
</s>
</p>
<p>
<s type="decl">
Third	RB	third
,	,	,
the	DT	the
gut	NN	gut
microbiota	NN	microbiota
plays	VBZ	play
a	DT	a
key	JJ	key
role	NN	role
in	IN	in
digestion	NN	digestion
,	,	,
absorption	NN	absorption
and	CC	and
synthesis	NN	synthesis
of	IN	of
metabolites	NNS	metabolite
such	JJ	such
as	IN	as
SCFAs	NNS	SCFAs
.	.	.
</s>
<s type="decl">
These	DT	this
metabolites	NNS	metabolite
are	VBP	be
directly	RB	directly
associated	VBN	associate
with	IN	with
environmental	JJ	environmental
factors	NNS	factor
such	JJ	such
as	IN	as
diet	NN	diet
and	CC	and
lifestyle	NN	lifestyle
.	.	.
</s>
<s type="decl">
Growing	VBG	Grow
evidence	NN	evidence
supports	VBZ	support
the	DT	the
concept	NN	concept
that	IN	that
,	,	,
in	IN	in
patients	NNS	patient
with	IN	with
IBS	NNP	IBS
,	,	,
specific	JJ	specific
diets	NNS	diet
could	MD	could
be	VB	be
associated	VBN	associate
to	IN	to
microbiota	NN	microbiota
modulation	NN	modulation
,	,	,
thus	RB	thus
adding	VBG	add
another	DT	another
piece	NN	piece
of	IN	of
the	DT	the
puzzle	NN	puzzle
to	IN	to
the	DT	the
gut	NN	gut
microbiota-IBS	NN	microbiota-IBS
link	NN	link
.	.	.
</s>
<s type="decl">
Of	IN	of
increasing	VBG	increase
interest	NN	interest
is	VBZ	be
the	DT	the
low	JJ	low
fermentable	JJ	fermentable
oligosaccharides	NNS	oligosaccharide
,	,	,
disaccharides	NNS	disaccharide
,	,	,
monosaccharides	NNS	monosaccharide
and	CC	and
polyols	NNS	polyol
(	-LRB-	(
FODMAPs	NNS	fodmap
)	-RRB-	)
diet	NN	diet
that	WDT	that
leads	VBZ	lead
to	IN	to
reduced	VBN	reduce
flatulence	NN	flatulence
and	CC	and
symptom	NN	symptom
relief	NN	relief
in	IN	in
some	DT	some
IBS	NNP	IBS
patients	NNS	patient
.	.	.
</s>
<s type="decl">
Nevertheless	RB	nevertheless
,	,	,
while	IN	while
the	DT	the
beneficial	JJ	beneficial
role	NN	role
of	IN	of
this	DT	this
diet	NN	diet
on	IN	on
microbiota	NN	microbiota
remains	VBZ	remain
unclear	JJ	unclear
,	,	,
a	DT	a
reduction	NN	reduction
of	IN	of
commensal	JJ	commensal
bacteria	NNS	bacteria
has	VBZ	have
been	VBN	be
reported	VBN	report
.	.	.
</s>
<s type="decl">
Hustoft	NNP	Hustoft
et	FW	et
al.	FW	al.
have	VBP	have
shown	VBN	show
a	DT	a
reduction	NN	reduction
in	IN	in
fecal	NN	fecal
<hi rend="italic">
Actinobacteria	NNP	Actinobacteria
</hi>
,	,	,
<hi rend="italic">
Bifidobacterium	NNP	Bifidobacterium
</hi>
and	CC	and
<hi rend="italic">
Fecalibacterium	NNP	Fecalibacterium
prausnitzii	NN	prausnitzii
</hi>
in	IN	in
patients	NNS	patient
on	IN	on
a	DT	a
low	JJ	low
FODMAPs	NNP	FodmaPs
diet	NN	diet
.	.	.
</s>
<s type="decl">
This	DT	this
warrants	VBZ	warrant
further	JJ	further
investigation	NN	investigation
on	IN	on
the	DT	the
potential	JJ	potential
negative	JJ	negative
effects	NNS	effect
of	IN	of
“	``	''
therapeutic	JJ	therapeutic
“	''	''
diets	NNS	diet
on	IN	on
gut	NN	gut
microbiota	NN	microbiota
.	.	.
</s>
</p>
</text>